Comparison of bronchodilators in acute bronchiolitis

B. Karadag, O. Ceran, E. Dursun, G. Guven, I. Ozahi, F. Karakoc, R. Hamutcu, S. Inan, E. Dagli (Istanbul, Turkey)

Source: Annual Congress 2002 - Bronchiolitis
Session: Bronchiolitis
Session type: Oral Presentation
Number: 236
Disease area: Paediatric lung diseases

Congress or journal article abstract

Abstract

The efficacy of bronchodilators remains to be still controversal in acute bronchiolitis. We investigated the effects of salbutamol and ipratropium bromide among 69 infants hospitalized for moderate to severe bronchiolitis at their first episode of wheezing. Patients were enrolled into the study between December 1998 and March 2000. Median age of the infants was 5 months (ranging 1 to 11 months). Study group was randomly assigned to nebulised salbutamol (S) (n: 24) (2.5 mg, q4h), ipratropium bromide (I) (n: 22) (0.25 mg, tid) or placebo (P) (n: 23) (2.5 cc serum saline, q4h). Oxygen saturation, clinical score (derived from respiratory rate, wheezing score, accessory muscle score and clinical condition), heart rate and physical examination were recorded at baseline, 30 minutes, 8 hours after admission and daily thereafter. All groups were similar in terms of age, duration of illness and severity of the disease. Although the baseline evaluations were similar in all groups, 30th minute clinical scores were better in S and I groups compared to P (p<0.05, p<0.05). S and A groups were also significantly better at 8th hour with lower clinical scores (5.8*1.1and 6.0*1.0 vs.7.4±]1.2, p<0.01) and higher oxygen saturation rates (95.1*4.6 and 93.5*4.1 vs. 89.6±]2.4%, p<0.01). Clinical scores, oxygen saturation and respiratory rates were significantly better in S group after 24 hours from admission compared to groups A and P (p<0.05). After 24 hours, daily evaluations were similar in all groups.
In that study group, salbutamol and ipratropium were found to be more effective than placebo in the management of acute bronchiolitis.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Karadag, O. Ceran, E. Dursun, G. Guven, I. Ozahi, F. Karakoc, R. Hamutcu, S. Inan, E. Dagli (Istanbul, Turkey). Comparison of bronchodilators in acute bronchiolitis. Eur Respir J 2002; 20: Suppl. 38, 236

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Inefficiency of montelukast in acute bronchiolitis
Source: Breathe 2008; 5: 272-273
Year: 2009

Comparative effectiveness of steroids and bronchodilators for the acute care of bronchiolitis
Source: Annual Congress 2010 - From viral bronchiolitis to recurrent pneumonia in childhood: diagnosis, treatment and underlying factors
Year: 2010


Comparison of treatments with nebulised salbutamol and epinephrine in acute bronchiolitis
Source: Eur Respir J 2004; 24: Suppl. 48, 344s
Year: 2004

Long-term outcome of infants treated for acute bronchiolitis with inhaled steroids
Source: Eur Respir J 2001; 18: Suppl. 33, 169s
Year: 2001

Acute viral bronchiolitis and acute asthma
Source: ERS Course 2018 - Summer school of paediatric respiratory medicine
Year: 2018

Acute viral bronchiolitis and acute asthma
Source: ERS Skills Course 2017 - Summer school of paediatric respiratory medicine
Year: 2017

Combined nebulization therapy in acute asthma exacerbation
Source: Eur Respir J 2001; 18: Suppl. 33, 47s
Year: 2001

Acute bronchiolitis in hospitalised patients: inappropriate use of corticosteroids
Source: Eur Respir J 2005; 26: Suppl. 49, 29s
Year: 2005

Utility of aerosolized budesonide therapy in acute moderate exacerbations of asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 283s
Year: 2003

Acute bronchiolitis in intants
Source: Annual Congress 2009 - Diagnosis and treatment of viral respiratory infections in early childhood
Year: 2009

Clinical efficacy of nebulised budesonide in acute exacerbation of COPD
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010

Mechanism by which inhaled bronchodilators prevent exacerbations in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics
Year: 2013


The role of nebulised budesonide in the treatment of acute exacerbations of COPD
Source: Eur Respir J 2007; 30: 399-400
Year: 2007


Role of viruses and atypical agents in COPD acute exacerbations
Source: Eur Respir J 2004; 24: Suppl. 48, 408s
Year: 2004

IV salbutamol as alternative treatment to intubation in RSV epidemic acute infantile bronchiolitis
Source: Annual Congress 2003 - New perspectives in bronchiolitis
Year: 2003


Aerosolized budesonide therapy in acute moderate exacerbations of Indian asthmatics
Source: Eur Respir J 2004; 24: Suppl. 48, 343s
Year: 2004

Treatment of acute asthma
Source: Eur Respir Mon 2012; 56: 172-187
Year: 2012


Nebulized therapy in bronchial asthma exacerbation
Source: Eur Respir J 2002; 20: Suppl. 38, 52s
Year: 2002

Inhaled corticosteroids in the treatment of acute asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 305s
Year: 2002

Do infants with bronchiolitis get any benefit with nebulized salbutamol?
Source: Annual Congress 2011 - Biological correlates and comorbidities of childhood asthma/allergy
Year: 2011